Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. [electronic resource]
Producer: 20060809Description: 985-95 p. digitalISSN:- 0315-162X
- Adolescent
- Arthritis, Juvenile -- drug therapy
- Child
- Child, Preschool
- Cyclooxygenase 2 Inhibitors -- adverse effects
- Cyclooxygenase Inhibitors -- adverse effects
- Dose-Response Relationship, Drug
- Female
- Half-Life
- Humans
- Lactones -- adverse effects
- Longitudinal Studies
- Male
- Meloxicam
- Naproxen -- adverse effects
- Sulfones -- adverse effects
- Thiazines -- therapeutic use
- Thiazoles -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.